Why Humana Inc. (HUM) stock moved
Humana Inc. (HUM) shares rose 4.6% to $430.92 as of November 6, 2026, a moderate gain from the prior close of $411.79. BestStocks flagged the session as a major change for HUM. The move is tied to an earnings beat. Below, we break down what changed for HUM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Beat
Humana Inc. (HUM) reported EPS of −$0.70 vs. −$1.00 estimate, beating consensus by 30.0%. HUM earnings scheduled for 2027-02-10 (date not yet confirmed) with consensus EPS estimate of −$7.84.
What it means for Humana Inc. investors
For Humana Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Positive 4.6% session move. Weighing against that: Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60; Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16. Wall Street's consensus price target sits at $469.89, implying +9.0% upside from $430.92. Over the past 90 days analysts logged 4 upgrades and 0 downgrades. BestStocks rates the overall signal quality medium (71/100). With earnings roughly 96 days out, the next report is the most likely near-term test of the move.
HUM price reaction
HUM last traded at $430.92, up $19.13 (+4.64%) from the previous close of $411.79. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $387.12 and $433.50, and it currently sits about 94% of the way up that band.
Bullish and bearish analyst opinions on Humana Inc. (HUM)
The consensus analyst price target on Humana Inc. (HUM) is $469.89, 9.0% above the recent $430.92. Over the past 90 days analysts logged 4 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HUM line up.
The bullish case
- Wall Street's consensus price target of $469.89 implies +9.0% upside from $430.92.
- The Street's most bullish target is $596.00 (+38.3%).
- 4 analyst upgrades in the past 90 days, most recently Raymond James to Outperform (2026-10-12).
- Earnings beat with positive market reaction.
- Positive 4.6% session move.
The bearish case
- The most bearish analyst target is $300.00 (-30.4%).
- Humana filed earnings today along with two material event 8-K filings (hum-20260728.htm and hum-20260729.htm), triggering a sharp 7.75% intraday decline to $358.60.
- Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 6, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HUM
In-depth HUM event analyses
Frequently asked questions about HUM
Why did Humana Inc. (HUM) stock move?
HUM rose 4.6% to $430.92. The move is associated with an earnings beat.
How much did HUM stock rise?
HUM gained 4.64% ($19.13) versus the prior close of $411.79, last trading at $430.92 on 0.9× average volume.
When is Humana Inc.'s next earnings date?
HUM's next earnings report is estimated for 2027-02-10 — about 96 days away.
What is the analyst price target for HUM?
The consensus analyst price target for HUM is $469.89, about 9.0% above the current $430.92. Over the past 90 days, analysts recorded 4 upgrades, 7 maintains, and 0 downgrades.
How BestStocks tracks HUM
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for HUM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 6, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.